Cargando…
Inclusion and diversity in the PRINCIPLE trial
Autores principales: | Patel, Mahendra G, Dorward, Jienchi, Yu, Ly-Mee, Hobbs, FD Richard, Butler, Christopher C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752781/ https://www.ncbi.nlm.nih.gov/pubmed/34119064 http://dx.doi.org/10.1016/S0140-6736(21)00945-4 |
Ejemplares similares
-
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
por: Dorward, Jienchi, et al.
Publicado: (2022) -
High-dose budesonide for early COVID-19 – Authors' reply
por: Hobbs, F D Richard, et al.
Publicado: (2021) -
Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
por: Butler, Christopher C, et al.
Publicado: (2021) -
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
por: Yu, Ly-Mee, et al.
Publicado: (2021) -
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
por: Hayward, Gail, et al.
Publicado: (2021)